News
Public · Published
DA Davidson maintains Amrize at Neutral, raises price target to $43 from $40
DA Davidson kept its Neutral rating on Amrize and raised its price target to $43 from $40, a 7.5% increase. The new target implies 3.3% upside from the October 29 close of $41.61.
Published:
Updated:
What happened
DA Davidson kept its Neutral rating on Amrize and raised its price target to $43 from $40, a 7.5% increase. The new target implies 3.3% upside from the October 29 close of $41.61.
Confirmed
Global impact / market context
A higher target with a Neutral rating means the analyst sees slightly more value but still does not recommend buying. Upside of 3.3% is small, so investors get little reward signal, and the mixed targets from other firms keep expectations unsettled.
Analyst inference
Recent analyst targets on Amrize range from $32 to $48 across five notes, showing wide disagreement about the company's worth. That spread can make the stock trade choppily as buyers and sellers react to each new rating or target change.
Analyst inference
What to watch
- Watch whether other analysts change their Amrize price targets or ratings after DA Davidson's move, since the current range runs from $32 to $48. Confirmed
- Watch whether Amrize's shares approach the $43 target; a move toward it would show investors accepting the analyst's higher valuation. Analyst inference
- Watch for upcoming company updates on profit, costs, or spending plans that could justify raising or lowering the $43 target. Proposed
Evidence
- Original source link unavailable